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Abstract
A strain of human CD3e transgenic mice, tge26, exhibits severe immunodeficiency associated with early arrest of T cell
development. Complete loss of T cells is observed in homozygous tge26 mice, but not in heterozygotes, suggesting that
genomic disruption due to transgenic integration may contribute to the arrest of T cell development. Here we report the
identification of the transgenic integration site in tge26 mice. We found that multiple copies of the human CD3e transgene
are inserted between the Sstr5 and Metrn loci on chromosome 17, and that this is accompanied by duplication of the
neighboring genomic region spanning 323 kb. However, none of the genes in this region were abrogated. These results
suggest that the severe immunodeficiency seen in tge26 mice is not due to gene disruption resulting from transgenic
integration.
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Introduction
Multiple strains of transgenic mice carrying high copy numbers
of the human CD3e (hCD3e) genomic sequence exhibit inhibited
development of T cells and natural killer cells [1]. It has been
suggested that an aberrant signal generated by the transgenic
hCD3e chain contributes to abrogated development of T cells and
natural killer cells [1,2]. However, among hCD3e transgenic lines,
the strain known as tge26 exhibits a unique and severe T cell
deficiency, in which T cell development is completely arrested at
an early stage in immature thymocytes before the expression of
CD4 or CD8 [1–3]. Defective T cell development in tge26 mice is
intrinsic to lymphoid progenitor cells rather than thymic stromal
cells, and is accompanied by accumulation of B cells in the thymus
[3]. Interestingly, the arrest of T cell development in tge26 mice is
specific for homozygotes and is not seen in heterozygotes [1–3].
Thus, it has been proposed that genomic alterations associated
with transgenic integration might contribute to perturbed T cell
development in tge26 mice [3,4]. Since tge26 mice are widely used
as a model of immunodeficiency [5–9], we sought to identify their
transgenic integration site.
Results and Discussion
The tge26 transgene is inserted between the Sstr5 and
Metrn loci on chromosome 17
To determine the location of the transgene integration site in
tge26 mice, we first performed fluorescence in situ hybridization
analysis of tge26
+/+ cells using the hCD3e transgenic construct as a
probe. A single signal was detected in the A2-B region of
chromosome 17 (data not shown). We then analyzed the linkage
between T cell deficiency and microsatellite markers on chromo-
some 17. This transgenic line was originally generated in (C57BL/
66CBA/J) F2 mice and maintained by backcrossing with C57BL/
6 mice [1]. We found that loss of CD3
+TCRb
+ T cells in the blood
was associated with homozygosity for CBA/J-derived microsatel-
lite markers on chromosome17. We determined that the linkage
between T cell deficiency and CBA/J-derived microsatellite
markers mapped to the region between D17mit55 and
D17mit44 (Fig. 1A), and further narrowed down the region to
the area between D17mit26-mit80-1 and D17mit 26-mit80-24,
which spans approximately 1 Mb (Fig. 1B).
We next performed Southern blot analysis of this genomic
region using pulse field gel electrophoresis (PFGE) of restriction
enzyme-digested genomic DNA fragments. We found that
among probes complementary to the 1 Mb genomic region
between D17mit26-mit80-1 and D17mit 26-mit80-24 (Fig. 2A,
probes a–g), a probe specific for the Sstr5 coding sequence (probe
c) detected a unique SalI fragment of approximately 200 kb in
genomic DNA isolated from tge26
+/+ but not wild-type (WT)
mice (Fig. 2B). The 200 kb SalI fragment was also detected by an
hCD3e probe, suggesting that this fragment contained the
hCD3e transgene (Fig. 2C). Interestingly, an 84 kb SalI fragment
detected in the WT genome did not disappear in the genome of
tge26
+/+ homozygous mice (Fig. 2B). Moreover, a probe specific
for Tekt4 coding sequence (Fig. 2A, probe b), which is located
only 19 kb away from the Sstr5 probe and which detected the
same 84 kb SalI fragment as the Sstr5 probe, failed to detect the
200 kb SalI fragment in tge26
+/+ g e n o m i cD N A( F i g .2 D ) .T h e
200 kb SalI fragment unique to tge26
+/+ genomic DNA was also
not detectable by any other probes from this region (Fig. 2A,
probes a, d, e, f, g) (data not shown). These results indicate that
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locus while preserving the neighboring Tekt4 sequence.
To identify the integration site, a genomic library was
constructed for tge26
+/+ mice and screened using the Sstr5 probe.
Sequence analysis of Sstr5
+ clones revealed that two of the clones
contained a sequence identical to that beginning at nt 9497 of the
24 kb hCD3e transgene (in intron 2 of the hCD3e genomic
sequence) but that this sequence was connected to the Sstr5 gene
14401 bp 39 of the transcription initiation site (Fig. 2E). PCR
analysis showed that genomic DNA from tge26
+/+ but not WT
mice was amplified by primers specific for hCD3e transgenic
sequence (CD3e9130F) and Sstr5 genomic sequence (TS1R)
(Fig. 2E, lanes 3, 4). However, PCR primers designed to amplify
the sequence between 14271 bp and 14532 bp, 39 of the Sstr5
transcription initiation site (TS1F and TS1R), where the hCD3e
transgene is inserted, successfully amplified genomic DNA from
tge26
+/+ as well as from WT mice (Fig. 2E, lanes 1 and 2).
Southern blot analysis verified that a probe specific for Sstr5
Figure 1. Linkage analysis of chromosome 17 with T cell deficiency in tge26 mice. Homozygous tge26 mice were crossed with
tge266C57BL/6 heterozygous mice. Peripheral blood cells from the offspring were 2-color stained for CD3 and TCRb. (A) Genomic DNA from 30
CD3
+TCRb
+ cell-positive mice and 29 CD3
+TCRb
+ cell-negative mice was assessed for the indicated microsatellite markers. (B) Genomic DNA from 3
CD3
+TCRb
+ cell-positive mice and 6 CD3
+TCRb
+ cell-negative mice was assessed for the indicated microsatellite markers. C: CBA/J homozygous
alleles, C/B: CBA/J and C57BL/6 heterozygous alleles, B: C57BL/6 homozygous alleles, -: not detected. Sequences of microsatellite markers located
between D17mit26 and D17mit80 are listed in Supplementary Table S1.
doi:10.1371/journal.pone.0014391.g001
Tge26 Integration Site
PLoS ONE | www.plosone.org 2 December 2010 | Volume 5 | Issue 12 | e14391Figure 2. Identification of the tge26 transgenic integration site. (A) Physical map of the genomic region between D17mit26-mit80-1 and
D17mit 26-mit80-24. a–q: probes for Southern blot analysis. Details of these probes are listed in Supplementary Table S2. 1–7: regions of quantitative
genomic PCR analysis. S: SalI, E: EcoRI, A: AseI, K: KpnI, Hp: HpaI, Sc: SacI. (B–D) PFGE Southern blot analysis of SalI-digested WT and tge26
+/+ genomic
DNA using the indicated probes. (E) Sequence of Sstr5-sequence-containing tge26
+/+ genomic clones that also contained hCD3e sequence (left).
Physical map of the transgenic integration site at the Sstr5 locus (middle). H: HindIII. i: probe for Southern blot analysis. TS1F, TS1R, and CD3e9130F:
primers for genomic PCR analysis. Genomic PCR analysis using TS1F/TS1R primers (lanes 1 and 2) and CDe9130F/TS1R primers (lanes 3 and 4) (right).
(F, G) Southern blot analysis of WT and tge26
+/+ genomic DNA digested with the indicated restriction enzymes using the indicated probes. (H)
Physical map of the transgenic integration site at the Metrn locus (left). N: NcoI. q: probe for Southern blot analysis. m7900, m8100, and CD3e23010F:
primers for genomic PCR analysis. i-1R, i-1F, i-2R, and i-2F: primers for inverse and nested PCR amplification. Sequence of tge26
+/+ genomic clones
containing both Metrn and hCD3e sequences (middle). Genomic PCR analysis using m7900/m8100 primers (lanes 1 and 2) and m7900/CD3e23010F
primers (lanes 3 and 4) (right). (I, J) PFGE Southern blot analysis of WT and tge26
+/+ genomic DNA digested with the indicated restriction enzymes
using the indicated probes. (K) Quantitative genomic PCR analysis of WT (open bars) and tge26
+/+ (black bars) genomic DNA. Primers 1–7 are shown
Tge26 Integration Site
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fragment of 4.1 kb in genomic DNA isolated from tge26
+/+ but
not WT mice (Fig. 2F). Again, the 2.9 kb HindIII fragment
detected in the WT genome was also present in the genome of
tge26
+/+ mice (Fig. 2F). These results indicate that the hCD3e
transgene is inserted in the Sstr5 locus of the tge26 allele, but that
the sequence between the Sstr5 and Tekt4 loci is preserved in
tge26
+/+ mice.
It should be noted that the 200 kb tge26-specific SalI fragment
reproducibly showed greater signal intensity than the co-detected
84 kb fragment found in both WT and tge26 genomic DNA
(Fig. 2B), whereas the 4.1 kb tge26-specific HindIII fragment was
comparable in intensity to the co-detected 2.9 kb fragment found
in WT and tge26 genomic DNA (Fig. 2F). The Sstr5 probe used in
Fig. 2B (probe c) detected a comparable amount of the tge26-
specific fragment, and the fragment shared by WT and tge26
genomic DNA after genomic DNA was digested with EcoRI (data
not shown). Thus, the differential intensity of the 200 kb and
84 kb fragments (Fig. 2B) may reflect a difference in methylation
status, which is known to affect SalI digestion.
The finding of a transgenic insertion at the Sstr5 locus with
preservation of the neighboring sequence suggested that this
genomic region is duplicated in the tge26 allele. To better
understand transgene integration in the tge26 allele, we performed
additional Southern blot analysis using various probes comple-
mentary to the candidate genomic region (Fig. 2A, probes h to q).
We found that a probe specific for sequence 7 kb 59 of the Metrn
gene (Fig. 2A, probe q), approximately 300 kb away from the Sstr5
locus, detected a unique NcoI fragment of 3.3 kb in genomic DNA
isolated from tge26
+/+ but not WT mice while retaining the 4.2 kb
WT fragment of tge26
+/+ genomic DNA (Fig. 2G). To sequence
the transgenic insertion at the Metrn locus, genomic DNA from
tge26
+/+ mice was digested with NcoI, self-ligated, and amplified
using inversely oriented PCR primers (Fig. 2H, i-1F, i-1R, i-2F,
and i-2R). Amplified PCR products were cloned and sequenced.
We found several clones containing hCD3e sequence with nt 290
of the transgene connected to sequence 7689 bp 59 of the Metrn
gene (Fig. 2H). Genomic PCR analysis confirmed that a primer
specific for the hCD3e transgene (CD3e23010F) and a primer
specific for the genomic sequence 59 of the Metrn locus (m7900)
amplified tge26
+/+, but not WT, genomic DNA (Fig. 2H, lanes 3
and 4). Primers specific to the genomic sequences interrupted by
the transgenic insertion (m7900 and m8100) amplified both
tge26
+/+ and WT genomic DNA (Fig. 2H, lanes 1 and 2). In
PFGE Southern blot analysis, no other transgene integration site
was detected in the candidate genomic region (Fig. 2I, J, and data
not shown). These results indicate that in the tge26 allele, in
addition to the insertion at Sstr5 locus, the hCD3e transgene is
inserted between the Metrn and Fbx116 loci without disrupting
neighboring sequences.
Tge26 transgenic insertion is accompanied by a genomic
duplication spanning 323 kb
The above results revealed that in the tge26 allele, multiple
copies of the hCD3e transgene spanning more than 200 kb are
found in the region between the Sstr5 and Metrn loci of
chromosome 17, but that these insertions do not disrupt the
intervening sequence. Therefore we speculated that transgenic
insertion in the tge26 allele is accompanied by duplication of the
neighboring genomic region, as previously demonstrated in
other transgenic mice [10–13]. Quantitative PCR analysis of
genomic DNA isolated from WT and tge26
+/+ mice showed that
the amount of DNA in the genomic region between the Sstr5
and Metrn loci (Fig. 2A, primer sets 2 to 6) was approximately 2-
fold higher in the tge26
+/+ genome than in the WT genome
(Fig. 2K). The amount of DNA in the neighboring sequences of
the Tekt4 and Fbxl16 loci (Fig. 2A, primer sets 1 and 7) and in
two additional control sequences located on chromosome 6
(Fig. 2K, ct-1 and ct-2) was not increased in the tge26
+/+
genome (Fig. 2K). The undistorted amplification curves for
these quantitative PCR reactions indicate that the 2-fold
elevation of DNA signal amplified by primer sets 2–6 reflects
the presence of 2-fold greater genomic DNA before amplifica-
tion rather than aberrant amplification efficiency in certain
PCR reactions (Supplementary Fig. S1). These results indicate
that transgenic integration of the tge26 allele is accompanied by
duplication of a 323 kb genomic region between the Sstr5 and
Metrn loci (Fig. 2L).
Genes surrounding the integrated tge26 transgene are
not disrupted
The genomic duplication of the region between the Sstr5 and
Metrn loci in the tge26 allele implies that none of the sequences
surrounding the transgenic insertion should be lost in the tge26
allele. Indeed, of the 45 genes located within the functionally
mapped genomic region between D17mit26-mit80-1 and D17mit
26-mit80-24 (Fig. 1B), none showed severely abrogated expres-
sion in tge26
+/+ newborn thymocytes, which remained B220
2
CD4
2CD8
2 before the development of B220
+ B cells [3], as
compared to newborn B220
2CD4
2CD8
2 thymocytes isolated
from TCRb
2/2d
2/2 mice (Supplementary Fig. S2). However, the
expression of Tpsb2, Gng13, Msln, Stub1, and Pdia2 in this genomic
region was more than 10-fold increased in tge26
+/+ thymocytes
(Supplementary Fig. S2), which may reflect enhanced expression
of these genes due to transcriptional accessibility of the
neighboring hCD3e transgene in immature T-lymphoid cells.
We also compared the expression of these 45 genes in DN1
thymocytes isolated from tge26
+/+,t g e26
+/2, and WT newborn
mice, and found that none were severely abrogated specifically in
tge26
+/+ thymocytes (Fig. 3A). The undistorted amplification
curves for these quantitative RT-PCR reactions indicate that the
PCR signals measured in these experiments faithfully reflect the
amount of mRNA transcripts expressed in the cells (Supplemen-
tary Fig. S3).
Interestingly, expression of Rhot2 was approximately 10-fold
reduced in tge26
+/+ thymocytes compared to WT and tge26
+/2
thymocytes (Fig. 3A). However, we found using OP9-DL1 co-
culture [14] that over-expression of Rhot2 did not rescue defective
T cell development from tge26
+/+ lymphoid progenitor cells (data
not shown), suggesting that the reduced expression of Rhot2 is not
primarily responsible for defective T cell development in tge26
+/+
mice. Expression of Lmf1, Hagh1, Wdr90, Gm10012 and Nme4 was
approximately 10-fold elevated in tge26
+/+ and tge26
+/2 thymo-
cytes compared to WT thymocytes (Fig. 3A). In addition,
expression of Tpsb2, Gng13, Msln, Ccdc78 and Pdia2 was detected
in tge26
+/+ and tge26
+/2 thymocytes but not in WT thymocytes
(Fig. 3A, gray bars), and expression of Gng13 and Msln was higher
in tge26
+/+ thymocytes than in tge26
+/2 thymocytes (Fig. 3A).
However, we found that over-expression of Gng13 or Msln did not
perturb T cell development from WT lymphoid progenitor cells in
in (A). ct-1 and ct-2 are the genomic regions from chromosome 6 used as controls. Primer sequences are shown in Supplementary Table S3. Data
were normalized to ct-1 signals. Means and standard errors of 3 independent measurements are shown. (L) Configuration of the tge26 allele.
doi:10.1371/journal.pone.0014391.g002
Tge26 Integration Site
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expression of Gng13 or Msln is not primarily responsible for
defective T cell development in tge26
+/+ mice. It was previously
reported that over-expression of Axin, a gene localized to this
genomic region, impairs T cell development [15]. However, the
expression of Axin was not greatly altered in tge26
+/+ thymocytes.
Nonetheless, among the 45 genes examined, we detected no
mutations in the coding sequences of 42 genes, while the other 3
Figure 3. Expression of genes surrounding the hCD3e transgenic integration site in tge26
+/+ thymocytes. (A) Quantitative PCR analysis
of mRNA expression in neonatal tge26
+/2 (open bars) and tge26
+/+ (black bars) thymocytes. Results were normalized to GAPDH mRNA and
quantitated relative to DN1 cells isolated from WT mice. The expression of Tpsb2, Gng13, Msln, Ccdc78 and Pdia2 in tge26
+/+ thymocytes (gray bars)
was quantitated relative to tge26
+/2 thymocytes, because expression of these genes was not detected in WT thymocytes. Means and standard errors
of 3 independent measurements are shown. nd: not detected. Primer sequences are shown in Supplementary Table S4. (B) RNA isolated from
thymocytes (Thy), splenocytes (Spl), bone marrow cells (BM), and genomic DNA (gDNA) of WT mice was electrophoresed on a polyacrylamide gel and
then blotted and probed for TS1F/TS1R sequence (Fig. 2E), m7900/m8100 sequence (Fig. 2H) and U6 small nuclear RNA. Representative results from
two independent experiments are shown.
doi:10.1371/journal.pone.0014391.g003
Tge26 Integration Site
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expression in lymphoid and other tissues (data not shown). Thus,
none of the genes surrounding the transgenic insertion site are
completely lost in the tge26 allele. These results suggest that the
severe T cell deficiency seen in tge26 mice is not due to disruption
of the genes surrounding the transgenic integration site. However,
it is possible that gross alterations of gene expression profiles in this
genomic region may contribute to the defective T cell develop-
ment of tge26 mice.
It is known that non-coding RNAs are involved in the
regulation of many genes [16,17]. We finally examined whether
transgenic insertion disrupts neighboring non-coding RNAs in
tge26
+/+ mice. No non-coding RNAs have been identified within
the genomic sequence 58 kb from the Metrn transgenic integration
site and 216 kb from the Sstr5 transgenic integration site (Ensembl
and miRBase databases). Moreover, probes complementary to
Sstr5 and Metrn sequences (the TS1F/TS1R and m7900/m8100
PCR products shown in Fig. 2E and 2H) gave no signals when
hybridized using blots with total RNAs isolated from thymocytes,
splenocytes, and bone marrow cells from WT mice, whereas U6
small nuclear RNA was detected in these cells using this method
(Fig. 3B). These results indicate that non-coding RNAs are not
located in the transgenic integration site and are not disrupted in
the tge26 allele.
Conclusion
We have identified the transgenic integration site of the tge26
+/+
allele and shown that tge26 transgenic insertion is accompanied by
duplication of neighboring sequences and that no neighboring
genes are lost in the tge26 allele. These results indicate that the
severe T cell deficiency unique to homozygous tge26 mice is not
due to gene disruption by transgenic integration. It is possible that
transgenic insertion alters the function of cis-acting elements
located in the neighboring sequences that regulate remotely
encoded genes that are critical for early T cell development. It is
also possible that T cell deficiency in tge26 mice is independent of
genomic alterations, and is completely due to the aberrantly
expressed hCD3e chain in homozygous tge26 lymphoid progen-
itor cells. Further elucidation of the mechanisms underlying T cell
deficiency in tge26 mice may lead to a better understanding of the
molecular mechanisms of early T cell development.
Methods
Ethics Statement
This study utilized experiments using mice. All experiments
using mice were performed with consent from the Animal
Experimentation Committee of the University of Tokushima
(Toku Dobutsu 08059). The study did not involve human
experiments.
Mice
Tge26 human CD3e-transgenic mice [1] and TCR-b/TCR-d
double knockout mice [18,19] were described previously. C57BL/
6 mice were purchased from SLC Japan. All experiments using
mice were performed with consent from the Animal Experimen-
tation Committee of the University of Tokushima.
Linkage analysis
Homozygous tge26 mice were crossed with tge266C57BL/6
heterozygous mice. Linkage analysis was performed as described
previously [20,21]. To determine phenotypes, peripheral blood
white cells were stained with FITC-conjugated antibody for TCRb
and biotinylated antibody for CD3 followed by staining with
phycoerythrin-conjugated streptavidin. Two-color flow cytometry
analysis was performed using FACS-Calibur (BD Biosciences).
Southern blot analysis
For PFGE analysis, genomic DNA was embedded in agarose
using the CHEF Genomic DNA Plug Kit (Bio-Rad), digested with
the indicated restriction enzymes, and electrophoresed in 1%
agarose using the CHEF Mapper XA system (Bio-Rad). For
conventional analysis, genomic DNA was digested and electro-
phoresed in 1% agarose. DNA was transferred to a nylon
membrane (Hybond-N+, GE Healthcare). Probes were labeled
with [a-
32P] dCTP using the Random Primer DNA Labeling Kit
(Takara Bio). The membranes were pre-hybridized for 30 min and
hybridized overnight at 42
oC in 50% formamide, 0.25 M NaCl,
0.12 M Na2HPO4, 7% SDS, and 100 mg/ml denatured herring
sperm DNA. Hybridized membranes were washed in 26 SSC,
0.1%SDS at 60
oC for 30 min and then in 0.26SSC, 0.1%SDS at
60
oC for 30 min, and exposed to Kodak Biomax MS X-ray film at
280
oC with an intensifying screen.
Molecular cloning
For phage library construction, tge26
+/+ genomic DNA was
partially digested with Sau3AI and cloned into the BamHI site of
the bacteriophage lEMBL3 (Promega). Recombinant bacterio-
phages were screened with
32P-labeled Sstr5 probe. For inverse
PCR, tge26
+/+ genomic DNA was digested with NcoI, and 2–3 kb
DNA fragments were extracted from agarose gel using the
QIAquick Gel Extraction Kit (Qiagen) and were self-ligated using
T4 DNA ligase (Takara) and PCR amplified using the i-1F (59-
TATCCGAGCCAAATGTGCCA-39) and i-1R (59-AGATA-
GAAACCTCAATGCCCA-39) primers. Primers used for nested
PCR were i-2F (59-GATGTTCCAAAAGCGTCATCAGG-39)
and i-2R (59-GCTGAAGTGCCAGGC TAATG-39). Amplified
fragments were cloned into the pCRII-X vector. DNA was
sequenced using a 3100 Genetic Analyzer (Applied Biosystems).
Genomic PCR analysis
Genomic DNA was PCR-amplified using the following primers:
TS1F (59-AGTTGCCCATGCTTCAGCGAGTA-39), TS1R (59-
CTGCCCATCCCAGTACATGCCT -39), CD3e9130F (59-GA-
GCGAAGCTCCACTCCTTGTT-39), m7900 (59-AGAGCC C-
AAGGAACAAGGGT-39), m8100 (59-CAACCACATGGTGG-
CTCACA-39) and CD3e23010F (59-GTGGTTGGGCCACAC-
TTTCA-39). For quantitative PCR analysis, genomic DNA was
PCR-amplified and analyzed using SYBR Green PCR Master
Mix (Takara) and a 7900HT Sequence Detection System (Applied
Biosystems). Amplified signals were confirmed to be single bands
using gel electrophoresis.
Cell sorting
Thymocytes were labeled with biotinylated CD4 and CD8
antibodies. CD4
2CD8
2 DN cells were purified by depleting
CD4
+ cells and CD8
+ cells using a magnetic cell sorter (Miltenyi
Biotec). DN cells were stained with FITC-conjugated antibody
specific for CD44 and phycoerythrin-conjugated antibody specific
for CD25 (BioLegend). CD44
+CD25
2 DN1 cells were sorted by
FACS AriaII (BD Biosciences).
Quantitative RT-PCR analysis
Total RNA isolated from neonatal thymocytes was treated with
RNase-free DNaseI (Takara) and reverse-transcribed using Super-
ScriptIII reverse transcriptase (Invitrogen). cDNA was PCR-
amplified and analyzed using SYBR Green PCR Master Mix
Tge26 Integration Site
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signals were confirmed to be single bands using gel electrophoresis,
and were normalized to GAPDH levels.
RNA blot analysis
Total RNA (10 mg) was loaded onto a 15% polyacrylamide gel
containing 7M urea, transferred to a nylon membrane, and
hybridized with genomic DNA fragments amplified from C57BL/
6 mice using TS1F/TS1R or m7900/m8100 primers. A U6 RNA
probe was also used. Hybridization was carried out at 42
oC
overnight as described for Southern blot analysis.
Supporting Information
Figure S1 Amplification curves for quantitative genomic PCR
reactions. PCR primers (ct-1, ct-2, and 1–7) are indicated at the
top of each plot.
Found at: doi:10.1371/journal.pone.0014391.s001 (0.68 MB TIF)
Figure S2 Quantitative PCR analysis of mRNA expression of
genes surrounding the hCD3e transgenic integration site in
neonatal tge26+/+ thymocytes. Results were normalized to
GAPDH mRNA and quantitated relative to TCRb2/2d2/2
neonatal thymocytes. Means and standard errors of 3 independent
measurements are shown. nd: not detected.
Found at: doi:10.1371/journal.pone.0014391.s002 (0.15 MB TIF)
Figure S3 Amplification curves for the quantitative RT-PCR
reactions. Names of the genes represented are indicated at the top
of each plot.
Found at: doi:10.1371/journal.pone.0014391.s003 (0.86 MB TIF)
Table S1
Found at: doi:10.1371/journal.pone.0014391.s004 (0.37 MB TIF)
Table S2
Found at: doi:10.1371/journal.pone.0014391.s005 (0.21 MB TIF)
Table S3
Found at: doi:10.1371/journal.pone.0014391.s006 (0.20 MB TIF)
Table S4
Found at: doi:10.1371/journal.pone.0014391.s007 (0.94 MB TIF)
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